Kolexia
Laureillard Didier
Médecine générale
Hôpital Carémeau
Nîmes, France
133 Activités
157 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Tuberculose Toxicomanie intraveineuse Hépatite C Hépatite COVID-19 Co-infection Syndrome inflammatoire de restauration immunitaire Troubles liés à une substance

Industries

MSD
1 collaboration(s)
Dernière en 2022
ViiV Healthcare
1 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam.
Diagnostics (Basel, Switzerland)   16 novembre 2023
Gender, homelessness, hospitalization and methamphetamine use fuel depression among people who inject drugs: implications for innovative prevention and care strategies.
Frontiers in psychiatry   01 novembre 2023
Utility of self-report antiretroviral adherence for predicting HIV viral load among persons who inject drugs in Hai Phong Vietnam: assessing differences by methamphetamine use.
AIDS care   01 novembre 2023
DRIVE-C: Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   25 octobre 2023
Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153).
Pathogens (Basel, Switzerland)   13 octobre 2023
Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype: ANRS 175 RHIVIERA-01: Assessment of HIV Remission Upon Combination Antiretroviral Therapy (cART) Interruption in Early Treated Individuals From ANRS CO6 PRIMO Cohort Carrying the Major Histocompatibility Complex (MHC) B35/53Bw4TTC2 Genotype
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   28 septembre 2023
RESERVIH32: Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment
Essai Clinique (CHU Nîmes)   26 septembre 2023
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area.
Harm reduction journal   29 juin 2023
A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam.
The Lancet regional health. Western Pacific   27 mai 2023
High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF® for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   08 mars 2023